NLRP3 initiates inflammation, leading to tissue damage and fibrosis in various conditions including alcoholic steatohepatitis, DILI, and NASH, through IL-17 and TNF-α [128]. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatohepatitis.